Welcome, Login to your account.
A password will be e-mailed to you.
Express Pharma - Express Pharma
Vivimed Labs, a niche specialty chemicals and pharma company announced that it received approvals for three ophthalmic products from its ophthalmic facility and three oral liquid suspension products from its PICS & Health Canada approved site. Both facilities are situated at Hyderabad.
The products are as follows:
Ambroxol is a mucolytic agent which reduces the thickness of the sputum. It is used to treat emphysema with bronchitis pneumoconiosis, tracheobronchitis and acute exacerbations of bronchitis
Salbutamol used to treat or prevent bronchospasm in patients with asthma, bronchitis, emphysema, and other lung diseases. This medicine is also used to prevent wheezing caused by exercise (exercise-induced bronchospasm).
Bromhexine hydrochloride is used to treat breathing difficulties caused by excessive mucus secretions in the air passages associated with respiratory tract infections.
Guaifenesin (Guaiphenesin or Glyceryl Guaiacolate) is an expectorant. It usually solves over the counter and helps treat congestion in your chest and throat by the common cold, infections, or allergies. The medicine is for a cough and cold to make it easier to cough out through your mouth.
Menthol is a topical analgesic. It works by temporarily relieving minor pain.
Terbutaline is used to treat breathing ailments symptoms like shortness of breath, chest tightness, wheezing etc.
Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (e.g., ocular hypertension).
Moxifloxacin is a quinolone antibiotic used to treat bacterial eye infections.
Ofloxacin is a quinolone antibiotic used to treat bacterial eye infections
Commenting on the approvals, Ramesh Krishnamurthy, CEO of Vivimed Labs said, “These six approvals mark yet another significant milestone for increasing the exports of Vivimed own brands to multiple countries. Vivimed shall be launching 10+ new products in 03/04 FY 2021.”
Demand for repurposed drugs to continue even after launch of COVID-19 vaccines: Experts
Sheffield University, Pfizer launch consortium for development of advanced therapy medicinal products
US CDC publishes guidelines on monkeypox vaccine
US FDA declines to approve Eton Pharma’s anti-seizure drug
Alniche Lifesciences unveils new office in Delhi
Informa Markets to organise PharmaLytica in Mumbai
Your email address will not be published.
Save my name, email, and website in this browser for the next time I comment.
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
Welcome, Login to your account.
A password will be e-mailed to you.